Купить СНПЧ А7 Архангельск, оперативня доставка


A Indução da Procura Mediante a Promoção da Chance Terapêutica - A Problemática dos Ganhos de Chance Promovidos pela Recomendação Médica em Tratamentos sem Efeito Discernível nos Pacientes

DOI: http://dx.doi.org/10.18836/2178-0587/ealr.v2n2p352-403



Ricardo R. Pereira1


Resumo: O presente artigo tem origem numa reflexão sobre artigos de natureza médica relativos a certo tipo de tratamentos ministrados a pacientes com cancro. Em tais artigos sublinha-se a falta de eficácia ou a desnecessidade de muitos desses tratamentos no âmbito de certas patologias cancerígenas, concluindo-se pela inexistência de qualquer efeito discernível nos pacientes que são sujeitos a tais procedimentos terapêuticos. Um contexto médico deste tipo convoca o problema dos custos significativos que o tratamento implica para o paciente. A prescrição médica desses tratamentos tem nessa medida de ser confrontada com o elenco de razões que pode explicar a circunstância de continuarem a ser objecto de recomendação médica em face da não evidência científica de sua eficácia. É exactamente esta contradição e suas causas que serão objecto de análise neste texto.

Palavras-chave: Tratamento Médico, Cancro, Ineficácia, Indução, Responsabilidade Civil.


Abstract: This article comes from a reflection upon certain medical treatments applied to cancer patients. These treatments emphasize the lack of efficacy or the unnecessity for many of these treatments for certain conditions carcinogenic, concluding for the absence of any discernible effect on patients who are subjected to such procedures. A medical context such as this brings the discution anout the significant costs involved in these treatments. The prescription of these treatments needs to that extent to be confronted with the reasons that might explain the fact that they continue to be subject to medical recommendation, event though there is no scientific evidence of its effectiveness. It is precisely this contradiction and its causes that are addressed in this paper.

Key words: Medical Treatment, Cancer, Ineffectiviness, Nudge, Liability


1 Faculdade de Direito da Universidade de Lisboa. e-mail: ricardo.pereira@linklaters.com.


Literatura Citada

Aaron, T., & Sebok, A.J. (2000). “Liability without cause? Further Ruminations on Cause-in-Fact as Applied To Handgun Liability”, Connecticut Law Review, 32:1379.

Abe, M.A. (1985). “Japan’s clinic physician and their behavior”, Social Science and Medicine, 20:335- 340. http://dx.doi.org/10.1016/0277-9536(85)90007-3

Ailor, S.K., & Miles, S.C. (2008). “Dermatology Toxicity”, in M.C. Perry (org.). The Chemotherapy Source Book, 4ª ed., Philadelphia, Lippincott Williams & Wilkins, 136-147.

Ambady, N., LaPlante, D., Nguyen, T., Rosenthal, R., Chaumeton, N., & Levinson, W. (2002). “Surgeons’ tone of voice: A clue to malpractice history”, Surgery 132(1):5-9. http://dx.doi.org/10.1067/msy.2002.124733

Araújo, F. (2005). Introdução à Economia, 3ª ed., Coimbra, Almedina.

Araújo, F. (2008). A Tragédia dos Baldios e dos Anti-Baldios – O Problema Económico do Nível Óptimo de Apropriação, Coimbra, Almedina.

Arrow, K. J. (1963). “Uncertainty and the welfare economics of medical care”, American Economic Review, 53:941-973.

Bach, P.B. (2009). “Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs”, New England Journal of Medicine, 360:626-633. http://dx.doi.org/10.1056/NEJMhpr0807774

Barrett, B.K., & Linebaugh, J.A. (2008). “Clinical Trials”, in M.C. Perry (org.). The Chemotherapy Source Book, 4ª ed., Philadelphia, Lippincott Williams & Wilkins, 37-43.

Barros, P.P. (2009). Economia da Saúde – Conceitos e Comportamentos, 2ª ed., Coimbra, Almedina.

Becker, E.R., & Sloan, F.A. (1983). “Utilization of hospital services: the roles of teaching, case mix, and reimbursement”, Inquiry, 20:248-257.

Bell, A. & Parchomovsky, G. (2003). “Of property and Anti-Property: The Perverse Virtues of Transaction Costs and Anticommons”, University of Pennsylvania Law School, Research Paper n.º 4, disponível em http://papers.ssrn.com/sol3/papers.cfm?abstract_id=387520.

Bennett, S. (1997). “The nature of competition among private hospitals in Bangkok” in S. Bennett, B. McPake, & A. Mills. (eds.). Private health providers in developing countries: serving the public interest?, London, Zed Books, 102-123.

Bennett, S., McPake, B., & Mills, A. (1997). Private health providers in developing countries: serving the public interest?, London, Zed Books.

Bentham, L., Maurizi, A., & Reder, M. (1968). “Location and migration medics: physicians and dentists”, Review of Economics and Statistics, 50:332-347. http://dx.doi.org/10.2307/1937927

Berlin, L. (2003). “Malpractice Issues in Radiology - Breast Cancer, Mammography, and Malpractice Litigation: The Controversies Continue”, American Journal of Roentgenology, 180:1229-1237. http://dx.doi.org/10.2214/ajr.180.5.1801229

Berry, D. (2004). “Commentary: Screening mammography: a decision analysis”, International Journal of Epidemiology, 33(1):68.

Birch, S. (1988). “The identification of supplier-inducement in a fixed price system of health care provision: The case of dentistry in the United Kingdom", Journal of Health Economics, 7:129-150. http://dx.doi.org/10.1016/0167-6296(88)90012-4

Blendon, R.J., Donelan, K., Leitman, R., Epstein, A., Cantor, J.C., Cohen, A.B., Morrison, I., Moloney, T. & Koeck, C. (1993). “Health reform lessons learned from physicians in three nations”, Health Affairs, 12(3):194-203. http://dx.doi.org/10.1377/hlthaff.12.3.194

Bollier, D. (2007). “The Growth of the Commons Paradigm”, in C. Hess, & E. Ostrom (eds.) (2007). Understanding Knowledge as a Commons – From Theory to Practice, Cambridge, Massachusetts Institute of Technology, 27-40.

Boyle, J. (2007). “Mertonianism Unbound: Imagining Free, Decentralised Access to Most Cultural and Scientific Material”, in C. Hess, & E. Ostrom. (2003). “Ideas, Artifacts, and Facilities: Information as a Common-Pool Resource”, Law & Contemporary Problems, 66: 135-137

Brennan, T.A., Rothman, D.J., Blank, L., Blumenthal, D., Chimonas, S.C., Cohen, J.J., Goldman, J., Kassirer, J.P., Kimball, H., Naughton, J., & Smelser, N. (2006). “Health Industry Practices That Create Conflicts of Interest. A Policy Proposal for Academic Medical Centers”, Journal of the American Medical Association, 295:429-433. http://dx.doi.org/10.1001/jama.295.4.429

Brown, M.L., Houn, F., Sickles, E.A.,& Kessler, L.G. (1995). “Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures”, American Journal of Roentgenology, 165:1373-1377. http://dx.doi.org/10.2214/ajr.165.6.7484568

Bull, A.R., & Campbell, M.J.(1991). “Assessment of the psychological impact of a breast screening programme”, The British Journal of Radiology, 64:510-515. http://dx.doi.org/10.1259/0007-1285-64-762-510

Cady, B. (1973). “Total mastectomy and partial axillary dissection”, Surgical Clinics of North America, 53(2):313-318. http://dx.doi.org/10.1016/S0039-6109(16)39983-2

Chassin, M.R., Kosecoff, J., Park, R.E., Winslow, C.M., Kahn, K.L., Merrick, N.J., Keesey, J., Fink, A., Solomon, D.H., & Brook, R.H. (1987). “Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures”, Journal of the American Medical Association, 258(18):2533-2537. http://dx.doi.org/10.1001/jama.1987.03400180067028

Childs, A.W., & Hunter, E.D. (1972). “Non-Medical Factors Influencing Use of Diagnostic X-Ray by Physicians” Medical Care, 10(4):323-335. http://dx.doi.org/10.1097/00005650-197207000-00005

Chimonas, S., & Rothman, D.J. (2005). “New Federal Guidelines for Physician-Pharmaceutical Industry Relations: The Politics of Policy Formation”, Health Affairs, 24(4):949-960. http://dx.doi.org/10.1377/hlthaff.24.4.949

Chou, Y.J., Yip, W.C., Lee,C-H., Huang, N., Sun, Y-P., & Chang, H.J. (2003). “Impact of separating drug prescribing and dispensing on provider behavior: Taiwan’s experience”, Health Policy and Planning, 18(3):316-329. http://dx.doi.org/10.1093/heapol/czg038

Christensen, S. (1992). “Volume responses to exogenous changes in Medicare's payment policies”, Health Services Research, 27(1):65-79.

Community Oncology Alliance. (2006). Medical News Today, 8 de Fevereiro, disponível em http://www.medicalnewstoday.com/articles/37346.php.

Cowling, K., & Cubbin, J. (1972). “Hedonic Price Indexes for United Kingdom Cars”, Economic Journal, 82:963-978. http://dx.doi.org/10.2307/2230261

Cromwell, ., & Mitchell, J.B. (1986). "Physician-Induced Demand for Surgery", Journal of Health Economics, 5:293-313. http://dx.doi.org/10.1016/0167-6296(86)90006-8

Culyer, A.J., & Newhouse, J.P. (2000). Handbook of Health Economics, Amsterdam, Elsevier.

Danzon, P. M., Manning, W.G., & Marquis, M.S. (1984). “Factors affecting laboratory test use and price”, Health Care Finance Review, 5(4):23-32.

Danzon, P.M. (2000). “Liability for medical malpractice”, in A.J. Culyer, & J.P. Newhouse. (2000). Handbook of Health Economics, Amsterdam, Elsevier: 1B:1339-1395.

Department of Health, Education and Welfare. (1980). “The Target Income Hypothesis and Related Issues in Health Manpower Policy”, Bureau of Health Manpower, DHEW (HRA). Washington DC, 80-127.

Doll, D.C., & Shahab, N. (2008). “Vascular Toxicity and Antineoplastic Agents”, in M.C. Perry (org.). The Chemotherapy Source Book, 4ª ed., Philadelphia, Lippincott Williams & Wilkins, 245-

Dranove, D., & Satterthwaite, M.A. (1991). “The implications for Source-Based relative Value Scales for Physicians’ Fees, Income and Specialty Choices”, in H.E. Frech III. (1991). Regulating Doctors’ Fees: competition, Benefits and Controls under Medicare, Washington DC, AEI Press:52-70.

Dranove, D., & Satterthwaite, M.A. (1992). “Monopolistic competition when price and quality are imperfectly observable”, The Rand Journal of Economics, 23(4): 518-534. http://dx.doi.org/10.2307/2555903

Dranove, D., & Satterthwaite, M.A. (1999). “The Industrial organization of health care markets” in A.J. Culyer, & J.P. Newhouse. (2000). Handbook of Health Economics, Amsterdam, Elsevier: 1B:1093-1140.

Dranove, D. (1988). “Demand inducement and the physician/patient relationship”, Economic Inquiry, 26:251-298. http://dx.doi.org/10.1111/j.1465-7295.1988.tb01494.x

Dranove, D., Shanley, M., & White, W.D. (1993). “Price and concentration in hospital markets: the switch from patient to payer driven completion”, Journal of Law and Economics, 36:179-204.

Eisenberg, J.M. (1986). Doctors’ Decisions and the Cost of Medical Care, Health Administration Press

Ellman, R., Angeli, N., Christians, A., Moss, S., Chamberlain, J., & Maguire, P. (1989). “Psychiatric morbidity associated with screening for breast cancer”, British Journal of Cancer, 60:781-784. http://dx.doi.org/10.1038/bjc.1989.359

Elmore, J.G., Barton, M.B., Moceri, V.M., Polk, S., Arena, P.J., & Fletcher, S.W. (1998). “Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations”, The New England Journal of Medicine, 338:1089-1096. http://dx.doi.org/10.1056/NEJM199804163381601

Elmore, J.G., Wells, C.K., Lee, C.H., Howard, D.H., & Feinstein, A.R. (1994). “Variability in Radiologists' Interpretations of Mammograms”, The New England Journal of Medicine, 331:1493- 1499. http://dx.doi.org/10.1056/NEJM199412013312206

Epstein, A.M., Begg, C.B., & McNeil, B.J. (1986). “The use of ambulatory testing in prepaid and feefor- service group practices: relation to perceived profitability”, The New England Journal of Medicine, 314:1089-1094. http://dx.doi.org/10.1056/NEJM198604243141706

Epstein, R. (1997). Mortal Peril: Our Inalienable Right to Health Care?, Reading, Massachusetts, Addison-Wesley Publishing Company, Inc.

Ernster, V.L., Barclay, J., Kerlikowske, K., Wilkie, H., & Ballard-Babash, R. (2000). “Mortality among women with ductal carcinoma in situ of the breast in the population-based Surveillance,

Epidemiology and End Results program”, Archives of Internal Medicine, 160:953-8.

Ernster, V.L., Ballard-Barbash, R., Barlow, W.E., Zheng, Y., Weaver, D.L., Cutter, G., Yankaskas, B.C., Rosenberg, R., Carney, P.A., Kerlikowske, K., Taplin, S.H., Urban, N., & Geller, B.M. (2002).

“Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography”, Journal of the National Cancer Institute, 94(20):1546-1554, Oxford University Press.

Escarce, J.J., & Pauly, M.V. (1998). “Physician opportunity costs in physician practice cost functions”, Journal of Health Economics, 17:129-151. http://dx.doi.org/10.1016/S0167-6296(97)00030-1

Evans, R.G. (1974). “Supplier-induced demand: some empirical evidence and implications”, in Perlman, M. (ed.) (1974). 162-173.

Fadul, R.(2009). “The Tragedy of the Commons Revisited”, The New England Journal of Medicine, 361(11):e115.

Feldstein, M.S. (1970). “The rising prices of physicians’ services”, Review of Economics and Statistics, 52(2):121-133. http://dx.doi.org/10.2307/1926113

Floyd, J.D., & Perry, M.C. (2008). “Cardiotoxicity in Cancer Therapy”, in Perry, M.C. (org.) (2008). 179-190.

Frank, R.G., (1985). “Pricing and location of physician services in mental health”, Inquiry 38:115- 133. http://dx.doi.org/10.1111/j.1465-7295.1985.tb01755.x

Frank, R.G., Weiner, J.P., Steinwachs, D.M., & Salkever, D.S. (1987). “Economic rents derived from hospital privileges in the market for pediatric services”, Journal of Health Economics, 6:319-337. http://dx.doi.org/10.1016/0167-6296(87)90019-1

Frech III, H.E., & Ginsburg, P.B. (1975). “Imposed health insurance in monopolistic markets: a theoretical analysis”, Economic Inquiry, 13:55-70. http://dx.doi.org/10.1111/j.1465-7295.1975.tb01103.x

Frech III, H. E. (1991). Regulating Doctors’ Fees: competition, Benefits and Controls under Medicare, Washington DC, AEI Press.

Freter, C.E., & Perry, M.C. (2008). “Principles of chemotherapy”, in Perry, M. C. (org.) (2008). 30- 36.

Friedman, J.Y., Curtis, L.H., Hammill, B.G., Dhillon, J.K., Weaver, C.H., Biswas, S., Abernethy, A.P., & Schulman, K.A. (2007), “The Medicare Modernization Act and reimbursement for outpatient chemotherapy: do patients perceive changes in access to care?”, Cancer, 110(10):2304-2312. http://dx.doi.org/10.1002/cncr.23042

Fuchs, V.R. (1974). Who Shall Live?, New York, Basic Books.

Fuchs, V.R. (1978). “The Supply of Surgeons and the Demand for Operations”, 13 Journal of Human Resources, 35:52-54. http://dx.doi.org/10.2307/145247

Fuchs, V.R. (1996). “Economics, values, and health care reform”, American Economic Review, 86:1- 24.

Gaynor, M., & Gertler, P. (1995). “Moral hazard and risk spreading in partnerships”, The Rand Journal of Economics, 26: 591-614. http://dx.doi.org/10.2307/2556008

Gaynor, M. (1994). “Issues in the industrial organization of the market for physician services”, The Journal of Economics & Management Strategy, 211-255. http://dx.doi.org/10.1111/j.1430-9134.1994.00211.x

Getzen, T.E. (1984). “A ‘brand name firm’ theory of medical group practice”, Journal of Industrial Economics, 33:119-215. http://dx.doi.org/10.2307/2098509

Gladwell, M. (2009). What the dog saw and other adventures, London, Penguin Books.

Goldie, J.H. (2008). “Drug Resistance”, in M.C. Perry (org.). The Chemotherapy Source Book, 4ª ed., Philadelphia, Lippincott Williams & Wilkins, 21-29.

Gram, I.T., & Slenker, S.E. (1992). “Cancer anxiety and attitudes toward mammography among screening attenders, non-attenders, and women never invited”, American Journal of Public Health, 82:249-251. http://dx.doi.org/10.2105/AJPH.82.2.249

Gram, I.T., Lund, E., & Slenker. S.E. (1990). “Quality of life following a false positive mammogram”, British Journal of Cancer, 62:1018-1022.

Grant, D. (2009). “Physician financial incentives and cesarean delivery: New Conclusions from the healthcare and utilization project Discussion”, Journal of Health Economics, 28(1):244-250. http://dx.doi.org/10.1016/j.jhealeco.2008.09.005

Greenfield, S., Nelson, E.C., Zubkoff, M., Manning, W., Rogers, W., Kravitz, R.L., Keller, A., Tarlov, A.R., & Ware Jr., J.E. (1992). “Variations in resource utilization among medical specialties and systems of care: results of the medical outcome study”, Journal of the American Medical Association, 267:1624-1630. http://dx.doi.org/10.1001/jama.1992.03480120062034

Gruber, J., & Owings, M. (1996). “Physician Financial Incentives and Cesarean Section Delivery”, The RAND Journal of Economics, 27(1): 99-123. http://dx.doi.org/10.2307/2555794

Gruber, J., Kim, J., & Mayzlin, D. (1999). “Physician Fees and Procedure Intensity: The Case of Cesarean Delivery”, Journal of Health Economics, 18:473-490. http://dx.doi.org/10.1016/S0167-6296(99)00009-0

Grytten, J., Holst, D., & Laake, P. (1990). “Supplier inducement – Its effect on dental services in Norway”, Journal of Health Economics, 9(4): 483-491. http://dx.doi.org/10.1016/0167-6296(90)90007-P

Grytten, J., Carlsen, F., & Sørensen, R. (1995). “Supplier Inducement in a Public Health Care System”, Journal of Health Economics, 14(2):207-229.

Hardin, G. (1968). "The Tragedy of the Commons", Science, 162:1243-1248. http://dx.doi.org/10.1126/science.162.3859.1243

Hassett, M.J., O’Malley, A.J., Pakes, J.R., Newhouse, J.P., & Earle, C.C. (2006). “Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer”, Journal of the National Cancer Institute, 98(16):1108-17. http://dx.doi.org/10.1093/jnci/djj305

Hemenway, D., Killen, A., Cashman, S.B., Parks, C.L., & Bicknell, W.J. (1990). “Physicians' Responses to Financial Incentives — Evidence from a for-Profit Ambulatory Care Center”, The New England Journal of Medicine, 322:1059-1063. http://dx.doi.org/10.1056/NEJM199004123221507

Hess, C., & Ostrom, E. (2003). “Ideas, Artifacts, and Facilities: Information as a Common-Pool Resource”, Law & Contemporary Problems, 66:111-145.

Hess, C., & Ostrom, E. (eds.) (2007). Understanding Knowledge as a Commons – From Theory to Practice, Cambridge, Massachusetts Institute of Technology.

Hickson, G.B., Altemeier, W.A., & Perrin, J.M. (1987). “Physician Reimbursement by Salary or Feefor- Service: Effect on Physician Practice Behavior in a Randomized Prospective Study”, Pediatrics, 80:344-350.

Hillman, B., Joseph, C., Mabry, M., Sunshine, J., Kennedy, S., & Noether, M. (1990). "Frequency and Costs of Diagnostic Imaging in Office Practice - A Comparison of Self-Referring and Radiologist-Referring Physicians", New England Journal of Medicine, 323(23):1604-1608. http://dx.doi.org/10.1056/NEJM199012063232306

Hillman, B.J., Olson, G.T., Griffith, P.E., Sunshine, J.H., Joseph, A.C., Kennedy, S.D., Nelson, W.R., & Bernhardt, L.B. (1992). “Physicians' utilization and charges for outpatient diagnostic imaging in a Medicare population”, Journal of the American Medical Association, 268(15):2050-2054. http://dx.doi.org/10.1001/jama.1992.03490150102032

Hillner, B., & Smith, T.J. (2009). “Efficacy Does Not Necessarily Translate to Cost Effectiveness: A Case Study in the Challenges Associated with 21st Century Cancer Drug Pricing”, Journal of Clinical Oncology, 27:2111-2113. http://dx.doi.org/10.1200/JCO.2008.21.0534

Hoerger, T.J., & Howard, L.Z. (1995). “Search behavior and choice of physician in the market for prenatal care”, Medical Care, 33:332-349. http://dx.doi.org/10.1097/00005650-199504000-00002

Holm, S. (2007). “Policy-Making in Pluralistic Societies”, in Steinbock, B. (ed.) (2007). 153-174.

Hsiao, W.C., Dunn, D.L. & Verrilli, D.K. (1993). “Assessing the Implementation of Physician- Payment Reform”, The New England Journal of Medicine, 328:928-933. http://dx.doi.org/10.1056/NEJM199304013281306

Hsiao, W.C., Braun, P., Yntema, D., & Becker, E.R. (1988). “Estimating Physicians' Work for a Resource-Based Relative-Value Scale”, The New England Journal of Medicine, 319:835-841. http://dx.doi.org/10.1056/NEJM198809293191305

Jacobson, M., Earle, C.C., Price, M., & Newhouse, J.P. (2010). “How Medicare’s Payment Cuts For Cancer Chemotherapy Drugs Changed Patterns Of Treatment”, Health Affairs, 29(7):1391-1399. http://dx.doi.org/10.1377/hlthaff.2009.0563

James, L.A., Mitchell, E.L., Menasce, L., & Varley, J.M. (1997). “Comparative genomic hybridisation of ductal carcinoma of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma”, Oncogene, 14:1059-1065. http://dx.doi.org/10.1038/sj.onc.1200923

Jennison, K., & Ellis, R.P. (1987). “Comparison of psychiatric service utilization in a single group practice under multiple insurance systems”, Advances in Health Economics and Health Services Research, 8:175-194.

Katz, D., Caplan, A.L., & Merz, J.F. (2003). "All Gifts Large and Small: Toward an Understanding of the Ethics of Pharmaceutical Industry Gift-Giving", American Journal of Bioethics, 3(3): 39-46. http://dx.doi.org/10.1162/15265160360706552

Keeler, E.B., & Brodie, M. (1993). “Economic Incentives in the Choice between Vaginal Delivery and Cesarean Section”, The Milbank Quarterly, 71(3):365-404. http://dx.doi.org/10.2307/3350407

Kessel, R. (1958). “Price discrimination in medicine”, Journal of Law and Economics, 1:20-53. http://dx.doi.org/10.1086/466540

Kessler, D.P., & McClellan, M. (1996). “Do doctors practice defensive medicine?”, Quarterly Journal Of Economics, 111:353-390. http://dx.doi.org/10.2307/2946682

Klevorick, A.K., & McGuire, T.G. (1987). “Monopolistic competition and consumer information: pricing in the market for psychologists’ services”, Advances in Health Economics and Health Services Research, 8:235-253.

Kranich, N. (2007). “Countering Enclosure: Reclaiming the Knowledge Commons”, in C. Hess, & E. Ostrom. (eds.) Understanding Knowledge as a Commons – From Theory to Practice, Cambridge, Massachusetts Institute of Technology: 85-122.

Kwon, S. (2003). “Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing”, Social Science & Medicine, 57(3):529-538. http://dx.doi.org/10.1016/S0277-9536(02)00378-7

Lalla, R.V., Peterson, D.E., Brennan, M.T., & Schubert, M.M. (2008). ”Oral Toxicity”, in Perry, M.C. (org.) (2008). 115-135.

Lambe, M., Hsieh, C-C., Tsaih, S-W., Ekbom, A., Trichopoulos,D., & Adami, H-O. (1998). “Parity age at first birth and the risk of carcinoma in situ of the breast”, International Journal of Cancer, 77:330-332. http://dx.doi.org/10.1002/(SICI)1097-0215(19980729)77:3%3C330::AID-IJC3%3E3.0.CO;2-P

Lawthers, A.G., Laird, N.M., Lipsitz, S., Hebert, L., Brennan, T.A., & Localio, A.R. (1992). “Physicians' Perceptions of the Risk of Being Sued”, Journal of Health Politics, Policy and Law , 17(3):463-482. http://dx.doi.org/10.1215/03616878-17-3-463

Lerman, C., Rimer, B.K., & Engstrom, P.F. (1991). “Cancer risk notification: psychosocial and ethical implications”, Journal of Clinical Oncology, 9:1275-1282.

Lerman, C., Trock, B., Rimer, B.K., Boyce, A., Jepson, C., & Engstrom, P.F. (1991). “Psychological and behavioral implications of abnormal mammograms”, Annals of Internal Medicine, 114:657-661. http://dx.doi.org/10.7326/0003-4819-114-8-657

Lerman, C., Trock, B., Rimer, B.K., Boyce, A., Jepson, C., Brody, D., & Boyce, A. (1991). “Psychological side effects of breast cancer screening”, Health Psychology, 10:259-267.

Levinson, W., Roter, D.L., Mullooly, J.P., Dull, V.T., & Frankel, R.M. (1997). “Physician-Patient Communication – The Relationship With Malpractice Claims Among Primary Care Physicians and Surgeons”, Journal of American Medical Association, 277(7):553-559. http://dx.doi.org/10.1001/jama.1997.03540310051034

Levitt, S.D. & Dubner, S.J. (2009). Superfreakonomics, London, Penguin Books.

Levy, J.M., Borowitz, M.J., Jencks, S.F., Kay, T.L., & Williams, D.K. (1990). “Impact of the Medicare fee schedule on payments to physicians”, Journal of the American Medical Association, 264(6):717-22. http://dx.doi.org/10.1001/jama.1990.03450060063030

Longnecker, M.P., Bernstein, L., Paganini-Hill, A., Enger, S.M., & Ross, R.K. (1996). “Risk factors for in situ breast cancer”, Cancer Epidemiol, Biomarkers & Prevention; 5:961-965.

Ma, K.-Z., Norton, E.C., Chou, S-Y., & Chou, Y-J. (2007). “Fertility Rate, Use of Cesarean Delivery and the Role of Information Gap: Evidence from Taiwan”, iHEA 6th World Congress: Explorations in Health Economics, disponível em SSRN: http://ssrn.com/abstract=991795.

Marsh, K.L, & Varley, J.M. (1998). “Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast”, British Journal of Cancer, 77:1439-1447. http://dx.doi.org/10.1038/bjc.1998.237

McGuire, T.G. (1983). “Physician’s trust and the quality of physicians”, Economic Inquiry, 21:203- 222. http://dx.doi.org/10.1111/j.1465-7295.1983.tb00626.x

McGuire, T.G., & Pauly, M.V. (1991). "Physician Response to Fee Changes with Multiple Payers", Journal of Health Economics, 10 (4): 385-410. http://dx.doi.org/10.1016/0167-6296(91)90022-F

McGuire, T.G. (2000). “Physician Agency”, in Culyer, A. J. & J. P. Newhouse (eds.) (2000). 1A: 461- 527.

McKinley, J.B., Potter, D.A., & Feldman, H.A. (1996). “Non-medical influences on medical decision-making”, Social Science and Medicine, 42:769-776. http://dx.doi.org/10.1016/0277-9536(95)00342-8

McPake, B., Kumaranayake, L., & Normand, C. (2008). Health Economics: an International Perspective, 2ª ed., New York, Routledge.

Mechanic, D. (1998). “The functions and limitations of trust in the provision of medical care”, Journal of Health Politics, Policy and Law, 23(4):661-686. http://dx.doi.org/10.1215/03616878-23-4-661

Melvin, J.S. (1998). “Ductal Carcinoma In Situ of the Breast: Controversial Issues”, The Oncologist, 3(2):94-103.

Miller, A.B., To, T., Baines, C.J., & Wall, C. (2000). “Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years”, Journal of the National Cancer Institute, 92:1490-1499. http://dx.doi.org/10.1093/jnci/92.18.1490

Mitchell, J.B., Wedig, G., & Cromwell, J. (1989). "The Medicare Physician Fee Freeze: What Really Happened?", Health Affairs, 8:21-33. http://dx.doi.org/10.1377/hlthaff.8.1.21

Mitchell, J.M., & Saas, T.R. (1995). “Physician ownership of ancillary services: indirect demand inducement or quality assurance?”, Journal of Health Economics, 14: 263-289. http://dx.doi.org/10.1016/0167-6296(95)00003-Z

Morgan, G., Wardy, R., & Bartonz, M. (2004). “The contribution of cytotoxic chemotherapy to 5- year survival in adult malignancies”, Clinical Oncology, 16:549-560. http://dx.doi.org/10.1016/j.clon.2004.06.007

Morgensztern, D., & Govidan, R. (2008). “Pulmonary Toxicity and Antineoplastic Therapy”, in M.C. Perry. (org.) (2008). The Chemotherapy Source Book, 4ª ed., Philadelphia, Lippincott Williams & Wilkins, 191-196.

Moss, R. (1995). “Questioning chemotherapy”, Equinox Press.

Neugut, A.I., & Uldrick, T. (2008). “Second Malignencies after chemotherapy” in Perry, M.C. (org.) (2008). 259-272.

Newhouse, J.P. (1970). “A Model of Physician Pricing” Southern Economic Journal, 37:174-183. http://dx.doi.org/10.2307/1056127

Newhouse, J.P., Williams, A.P., Bernett, B.W., & Schwartz, W.B. (1982). “Does the geographical distributions of physicians reflect market failure?”, Bell Journal of Economics, 13:493-505. http://dx.doi.org/10.2307/3003469

Nguyen, N.X., & Derrick, F.W. (1997). “Physician Behavioral Response to a Medicare Price Reduction”, Health Services Research, 32:289-298.

Nguyen-Kim, L., Or, Z., Paris, V., & Sermet, C. (2005). “The politics of drug reimbursement in England, France and Germany”, Health economics letter, n° 99.

Nielsen, A., Thomsen, J., Primdahl, S., Dyreborg, U., & Andersen, J. (1987). “Breast cancer and atypia among young and middle-aged women: A study of 110 medicolegal autopsies”, British Journal of Cancer, 56(6):814-819. http://dx.doi.org/10.1038/bjc.1987.296

OIG. (2003). Office of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers, disponível em http://oig.hhs.gov/fraud/docs/complianceguidance/042803pharmacymfgnonfr.pdf, 1-56.

Or, Z. (2002). Labour Market and Social Policy – Improving the Performance of Health Care Systems: From Measures to Actions (a Review of Experiences in Four OECD Countries). occasional papers no. 57, Paris OCDE.

Pacey, S., Li Wan Po, A. (1998). “A review of methods of drug cost management in hospitals”, Journal of Clinical Pharmacy and Therapeutics, 23(3):171-177. http://dx.doi.org/10.1046/j.1365-2710.1998.00140.x

Paskett, E.D., & Rimer, B.K. (1995). “Psychosocial effects of abnormal Pap tests and mammograms: a review”, Journal of Womens Health, 4:73-82. http://dx.doi.org/10.1089/jwh.1995.4.73

Pauly, M. (1980). Doctors and Their Workshops: Economic Models of Physician Behavior, Chicago, University of Chicago Press.

Pauly, M.V., & Satterthwaite, M.A. (1981). “The Pricing of Primary Care Physicians Services: A Test of the Role of Consumer Information”, The Bell Journal of Economics, 12(2):488-506. http://dx.doi.org/10.2307/3003568

Pauly, M.V. (1978). “Medical staff characteristics and hospital costs”, Journal of Human Resources, 13: 77-114. http://dx.doi.org/10.2307/145249

Pauly, M.V. (1979). “The ethics and economics of kickbacks and fee-splitting”, Bell Journal of Economics, 10:344-352. http://dx.doi.org/10.2307/3003336

Pauly, M.V. (1988). “Is medical care different? Old questions, new answers”, Journal of Health Politics, Policy and Law, 13:227-237. http://dx.doi.org/10.1215/03616878-13-2-227

Pauly, M.V. (1991). “Fee schedules and utilization”, in H. E. Frech III (ed.) (1991). 288-305. http://dx.doi.org/10.1215/03616878-13-2-227

Pedro, R.T. (2008). A Responsabilidade Civl do Médico – Reflexões sobre a Noção de Perda de Chance e a Tutela do Doente Lesado, Coimbra, Coimbra Editora.

Perlman, M. (ed.) (1974). The Economics of Health and Medical Care, London, The Macmillan Press Ltd.

Perry, M.C. (org.) (2008). The Chemotherapy Source Book, 4ª ed., Philadelphia, Lippincott Williams & Wilkins.

Phelps, C.E. (1997). Health Economics, 2ª ed., Harper Collins, New York.

Picus, J., & Martin, M.G. (2008). “Gastrointestinal Complications of Chemotherapy”, in M.C. Perry. (org.) (2008). The Chemotherapy Source Book, 4ª ed., Philadelphia, Lippincott Williams & Wilkins: 197-208.

Radecki, S.E., & Steele, J.P. (1990). “Effect of on-site facilities on use of diagnostic radiology by nonradiologists”, Investigative Radiology, 25:190-193. http://dx.doi.org/10.1097/00004424-199002000-00017

Ramsey, S.D., Moinpour, C.M., Lovato, L.C., Crowley, J.J., Grevstad, P., Presant, C.A., Rivkin, S.E., Kelly, K., & Gandara, D.R. (2002). “Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer”, Journal of the National Cancer Institute, 94(4):291-297. http://dx.doi.org/10.1093/jnci/94.4.291

Reinhardt, U.E. (1989). “Economists in health care: saviors or elephants in a porcelain shop?”, American Economic Review, 79: 337-342.

Rice, T.H. (1983). “The impact of changing Medicare reimbursement rates on physician induced demand”, Medical Care, 21(8); 803-815.

Rizzo, J.A., & Blumenthal, D. (1996). “Is the target income hypothesis an economic heresy?”, Medical Care Research and Review, 243-293. http://dx.doi.org/10.1177/107755879605300301

Rochaix, L. (1989). “Information Asymmetry and Search in the Market for Physicians' Services”, Journal of Health Economics, 8:53-84. http://dx.doi.org/10.1016/0167-6296(89)90009-X

Rodwin, M.A. (1993). Medicine, Money, and Morals: Physicians’ Conflicts of Interest, New York, Oxford University Press.

Satterthwaite, M.A. (1979). “Consumer Information, Equilibrium Industry Price, and the Number of Sellers”, The Bell Journal of Economics, 10(2):483-502. http://dx.doi.org/10.2307/3003348

Scherer, F. M. (2000). “The pharmaceutical industry”, in A.J. Culyer, & J.P. Newhouse. (2000). Handbook of Health Economics, Amsterdam, Elsevier. 1B:1297-1332.

Schroeder, S.A. (1992). “Physicians supply and the US medical market place”, Health Affairs, 11:235- 243. http://dx.doi.org/10.1377/hlthaff.11.1.235

Shahab, I., & ,Patterson, W.P. (2008). “Renal and Electrolyte Abnormalities due to Chemotherapy”, in Perry, M.C. (org.) (2008). 223-233.

Shane, M., & Roemer, M.I. (1959). “Hospital costs relate to supply of beds”, Modern Hospital, 92:71.

Shnoor, B. (2009). “Loss of Chance: A Behavioral Analysis of the Different Between Medical Negligence and Toxic Torts”, American Journal of Trial Advocacy, 33:71-112.

Simon, H.A. (1958). “Theories of decision-making in economics and behavioral science”, American Economic Review, 49:253-283.

Sørensen, R.J., & Grytten, J. (1999). ”Competition and supplier-induced demand in a health care system with fixed fees”, Health Economics, 8(6):497-508. http://dx.doi.org/10.1002/(SICI)1099-1050(199909)8:6%3C497::AID-HEC439%3E3.0.CO;2-D

Stano, M. (1987). “A further analysis of the physician inducement controversy”, Journal of Health Economics, 6:229-238. http://dx.doi.org/10.1016/0167-6296(87)90010-5

Stearns, S.C., Wolfe, B.L., & Kindig, D.A. (1992). “Physician responses to fee-for-service and capitation payment”, Inquiry, 29(4):416-425.

Steinbock, B. (ed.) (2007). The Oxford Handbook of Bioethics, Oxford, Oxford University Press.

Strasser, R.P., Bass, M.J., & Brennan, M. (1987). “The effect of an on-site radiology facility on radiologic utilization in family practice”, Journal of Family Practice, 24(6):619-23.

Suber, P. (2007). “Creating an Intellectual Commons through Open Access”, in C. Hess, & E. Ostrom (eds.) Understanding Knowledge as a Commons – From Theory to Practice, Cambridge, Massachusetts Institute of Technology. 171-208.

Sutton, S., Saidi, G., Bickler, G., & Hunter, J. (1995). “Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England”, Journal of Epidemiol Community Health, 49:413-418. http://dx.doi.org/10.1136/jech.49.4.413

Tolchin, M. (1989). “Medicare change is seen altering fees for doctors”, New York Times, A1-A17.

Trentham-Dietz, A., Newcomb, P.A., Storer, B.E., & Remington, P.L. (2000). “Risk factors for carcinoma in situ of the breast”, Cancer Epidemiol, Biomarkers & Prevention, 9:697-703.

U.S. Department of Health and Human Services. (1997). “Excessive Medicare payments for prescription drugs”, Washington DC: OIG, Report n.º OEI-03-96-00290.

U.S. General Accounting Office. (2001). “Medicare: payments for covered outpatient drugs exceed providers’ cost” Washington DC: GAO, Report n.º GAO-01-1118.

U.S. Government Accountability Office. (2005). “Medicare chemotherapy payments: new drug and administration fees are closer to providers’ costs”, Washington DC: GAO, Report n.º GAO-05- 142R.

Warnberg, F., Bergh, J., & Holmberg, L. (1999). “Prognosis in women with a carcinoma in situ of the breast: a population-based study in Sweden”, Cancer Epidemiol, Biomarkers & Prevention, 8:769-774.

Wazana, A. (2000). "Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?", Journal of the American Medical Association, 283(3):373-380. http://dx.doi.org/10.1001/jama.283.3.373

Welch, H.G., & Black, W.C. (1997). “Using autopsy series to estimate the disease ‘reservoir’ for ductal carcinoma in situ of the breast: how much more breast cancer can we find?”, Annals of Internal Medicine, 127:1023-1028.

Welch, H.G. (2004). Should I Be Tested For Cancer? – Maybe Not and Here is Why, Berkeley, University of California Press. http://dx.doi.org/10.7326/0003-4819-127-11-199712010-00014

Woodward, R.S., Schnitzler, M.A., & Kuols, L.K. (1998). “Reduced uncertainty as a diagnostic benefit”, Health Economics, 7:149-160. http://dx.doi.org/10.1002/(SICI)1099-1050(199803)7:2%3C149::AID-HEC321%3E3.0.CO;2-B

Woolf, S.H. & Stange, K.C. (2006). “A sense of priorities for the healthcare commons”, American Journal of Preventive Medicine, 31(1):99-102. http://dx.doi.org/10.1016/j.amepre.2006.03.010

Yip, W. (1998). “Physician responses to medical fee reductions: changes in the volume of coronary artery bypass graft (CABG) surgeries in the Medicare and private sectors”, Journal of Health Economics, 17(6):675-700. http://dx.doi.org/10.1016/S0167-6296(98)00024-1

Zhuang, Z., Merino, M.J., Chuaqui, R., Liotta, L.A., & Emmert-Buck, M.R. (1995). “Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer”, Cancer Research, 55:467-471.

Zuckerman, S., & Holahan, J. (1991). “Medicare balance billing: its role in physician payment”, in H.E., Frech III. Regulating Doctors’ Fees: competition, Benefits and Controls under Medicare, Washington DC, AEI Press. 143-169.